Top 21 LifeMine Therapeutics investors
The most complete profiles first. Showing 21 of 21.
Alex WongVerified
Hedge Fund, Venture Capital, Private Equity Firm
Series AHealth CareE-commerceLeisureEnterprise SoftwarePortfolio: Berry Genomics, Chengjia Apartment, LifeMine Therapeutics, China Chengxin Credit and 24 more
Verified email available
Brett ZbarVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more
Verified email available
Carol SuhVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
David CruikshankVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHardwarePortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Dennis RyanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Dorothy MargolskeeVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Jim TananbaumVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareBiotechnologyConsumer HealthElectronic Health Records (EHR)Portfolio: Element Biosciences, Peloton Therapeutics, Genomics, Keros Therapeutics and 8 more
Verified email available
Krishna YeshwantVerified
Venture Capital, Corporate Venture Capital, Investor · United States
Series BHealth CareTelecommunicationsHospitalsE-commercePortfolio: Pixie, Dialpad, Science 37, Synack and 90 more
Verified email available
Matt TaylorVerified
Venture Capital, Advisor, Private Equity Firm · United Kingdom
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Rhonda KaufmanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Sean KendallVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareEnterprise SoftwareEnergyChemicalPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Karim FarisVerified
Venture Capital, Corporate Venture Capital · United States
Health CareTelecommunicationsE-commerceConsumer GoodsPortfolio: Pixie, Dialpad, Science 37, Synack and 87 more
Verified email available
Mark McDonnellVerified
Venture Capital · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Tom BrennanVerified
Venture Capital, Private Equity Firm · United States
Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Corey Ritter
Venture Capital, Investor · United States
Series BHealth CareLife ScienceRoboticsManufacturingPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Luke Bagaason, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Nilay Thakar
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Richard Lau, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Steve Gillis
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more
Contact details available
Robert Nelsen
Venture Capital, Investor · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more
Contact details available
Rick KlausnerVerified
Angel/Individual, Investment Partner · United States
Consumer GoodsFood and BeverageInnovation ManagementPortfolio: LifeMine Therapeutics, Meatable, bit.bio, Wisdo
Verified email available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many LifeMine Therapeutics investors are on Angel Roster?
Angel Roster lists 21 LifeMine Therapeutics investors. 15 of them (71%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (20), Private Equity Firms (13) and Corporate Venture Capital Firms (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do LifeMine Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (8), Series B (7) and Series A (1).
Where are LifeMine Therapeutics investors based?
Most are based in the United States (18) and the United Kingdom (2).
Which companies have LifeMine Therapeutics investors backed?
The most-backed portfolio companies among them are Insitro (18), Remix Therapeutics (16), Mindstrong (16), Bit Bio (16) and Maze Therapeutics (16).
How do I contact LifeMine Therapeutics investors?
Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.